Stay updated on Safety of PBCAR20A in NHL/CLL Clinical Trial
Sign up to get notified when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.

Latest updates to the Safety of PBCAR20A in NHL/CLL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a government operations notice and a version bump to v3.2.0; removed the previous v3.1.0 tag. If any critical content relies on live status, users should review the new notice and links.SummaryDifference4%

- Check34 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check48 days agoChange DetectedUpdated to revision v3.0.2; v3.0.1 was removed and the 'Back to Top' link was deleted. Overall, this is a minor, non-content-changing update.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has been updated to include new drug information and resources related to B-cell chronic lymphocytic leukemia, while removing previous references to chronic graft versus host disease and other related conditions.SummaryDifference5%

- Check77 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.9%

Stay in the know with updates to Safety of PBCAR20A in NHL/CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.